CEA

You have access
Alternating Oxaliplatin and Irinotecan Chemotherapy Combined With Capecitabine and Bevacizumab for Microsatellite-stable Stage IV Metastatic Colon Cancer With a BRAF V600E Mutation: Two Case Reports Indicating Survival Improvement over Standard Therapy
YAOYI ZHANG, XIAOHUI LI, SHENG LI, ZHIJIAN YANG, ROBERT M. HOFFMAN and CHEN YU

Anticancer Research January 2025, 45 (1) 399-404; DOI: https://doi.org/10.21873/anticanres.17428
Open Access
Refined Diagnosis of Pleural Effusions by Immunocytochemistry of Cell Blocks
HIRSH KOYI and ERIK WILANDER

Anticancer Research February 2023, 43 (2) 669-673; DOI: https://doi.org/10.21873/anticanres.16204
You have access
Clinically Applicable Serum Biomarkers Among 14 Candidates Associated With Recurrence of Stage II and III Colorectal Cancer
CHAN WOOK KIM, YE JIN HA, KA HEE TAK, SEON AE ROH, SEON-KYU KIM, SEON-YOUNG KIM, YONG SUNG KIM, DONG-HYUNG CHO and JIN CHEON KIM

Anticancer Research September 2021, 41 (9) 4651-4658; DOI: https://doi.org/10.21873/anticanres.15279
You have access
Alpha-fetoprotein for Gastric Cancer Staging: An Essential or Redundant Tumor Marker?
CHUN-YI TSAI, KENG-HAO LIU, CHENG-TANG CHIU, SHUN-WEN HSUEH, CHIA-YEN HUNG, JUN-TE HSU, NGAN-MING TSANG, YU-SHIN HUNG and WEN-CHI CHOU

Anticancer Research May 2021, 41 (5) 2711-2718; DOI: https://doi.org/10.21873/anticanres.15052
You have access
Prognostic Role for CYFRA 21-1 in Patients With Advanced-stage NSCLC Treated With Bevacizumab Plus Chemotherapy
MARTIN SVATON, JIRI BLAZEK, GABRIELA KRAKOROVA, MILOS PESEK, MARCELA BURESOVA, ZUZANA TEUFELOVA, JOSEF VODICKA, KAROLINA HURDALKOVA, MAGDA BARINOVA and ONDREJ TOPOLCAN

Anticancer Research April 2021, 41 (4) 2053-2058; DOI: https://doi.org/10.21873/anticanres.14974
You have access
Evaluation of Serum Biomarker CEA and Ca-125 as Immunotherapy Response Predictors in Metastatic Non-small Cell Lung Cancer
MAX R. CLEVERS, ELISABETH A. KASTELIJN, BAS J.M. PETERS, HANS KELDER and FRANZ M.N.H. SCHRAMEL

Anticancer Research February 2021, 41 (2) 869-876; DOI: https://doi.org/10.21873/anticanres.14839
You have access
Diagnostic Accuracy of Pleural Fluid Cytology, Carcinoembryonic Antigen and C-Reactive Protein Together in Patients With Pulmonary Metastases and Malignant Pleural Effusion
STEFANO M.M. BASSO, ALESSANDRO DEL CONTE, UMBERTO ZUCCON, SANDRO C. SULFARO, GIOVANNI FANTI, FEDERICA MAFFEIS, PAOLO UBIALI, MARIO ERMANI and FRANCO LUMACHI

Anticancer Research October 2020, 40 (10) 5877-5881; DOI: https://doi.org/10.21873/anticanres.14607
You have access
Co-localisation of Glandular and Squamous Cell Markers in Non-small Cell Lung Cancer
HIRSH KOYI, EVA BRANDÉN, IHSAN KASIM and ERIK WILANDER

Anticancer Research June 2018, 38 (6) 3341-3346; DOI: https://doi.org/10.21873/anticanres.12600
You have access
CEA, CA 15-3, and TPS as Prognostic Factors in the Follow-up Monitoring of Patients After Radical Surgery for Breast Cancer
SARKA SVOBODOVA, RADEK KUCERA, ONDREJ FIALA, MARIE KARLIKOVA, ANDREA NARSANSKA, ILONA ZEDNÍKOVÁ, VLADISLAV TRESKA, DAVID SLOUKA, MILENA ROUSAROVA, ONDREJ TOPOLCAN and JINDRICH FINEK

Anticancer Research January 2018, 38 (1) 465-469;
You have access
Measuring Intragastric Tumor Markers in Gastric Cancer Patients: a Systematic Literature Review on Significance and Reliability
EDOARDO VIRGILIO, ANTONELLA PROIETTI, ROSARIA D'URSO, PATRIZIA CARDELLI, ENRICO GIARNIERI, MONICA MONTAGNINI, MARIA ROSARIA GIOVAGNOLI, PAOLO MERCANTINI, GENOVEFFA BALDUCCI and MARCO CAVALLINI

Anticancer Research June 2017, 37 (6) 2817-2821;

Main menu

User menu

Search

CEA

Pages